We are happy to announce that Haplogen GmbH and the Metabolomics unit of the VBCF completed their first pharmacokinetics study. Haplogen has been granted an 10,000 EUR “Innovation Voucher” from the Austrian Research Promotion Agency (FFG) for this project. Here, the FFG supports research cooperation between academia and SMEs. The successful project has been spearheaded on the analytical side by Dr. Gerlinde Grabmann (picture). It was the first project of the VBCF which was based on an FFG-funded “Innovation Voucher”. The completed study has laid the cornerstone of a mutual beneficial research cooperation between Haplogen and the Metabolomics unit of the VBCF.